Cogent Biosciences, Inc. Quarterly Operating Lease, Liability in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Cogent Biosciences, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q4 2024.
  • Cogent Biosciences, Inc. Operating Lease, Liability for the quarter ending December 31, 2024 was $17.5M, a 7.35% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $17.5M -$1.39M -7.35% Dec 31, 2024 10-K 2025-02-25
Q4 2023 $18.9M -$796K -4.05% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $19.6M +$16.5M +523% Dec 31, 2022 10-K 2023-03-14
Q3 2022 $20.1M +$16.4M +444% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $28.1M +$23.9M +566% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.52M -$1.2M -25.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.16M -$2.05M -39.4% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $3.69M -$1.99M -35% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $4.22M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $4.72M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $5.21M -$825K -13.7% Dec 31, 2020 10-K 2021-03-16
Q3 2020 $5.68M -$733K -11.4% Sep 30, 2020 10-Q 2020-11-09
Q4 2019 $6.03M Dec 31, 2019 10-K 2020-03-26
Q3 2019 $6.41M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $6.79M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $7.15M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.